Chimiothérapie intrapéritonéale dans le cancer de l'ovaire

Tretarre, 2003 Benedet, 2000, FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology, Int. J. Gynaecol. Obstet., 70, 209, 10.1016/S0020-7292(00)90001-8 Cannistra, 2004, Cancer of the ovary, N. Engl. J. Med., 351, 2519, 10.1056/NEJMra041842 Bell, 2006, Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study, Gynecol. Oncol., 102, 432, 10.1016/j.ygyno.2006.06.013 Aletti, 2007, Current management strategies for ovarian cancer, Mayo Clin. Proc., 82, 751, 10.1016/S0025-6196(11)61196-8 Weisberger, 1955, Use of nitrogen mustard in treatment of serous effusion of neoplasic origin, JAMA, 159, 1704, 10.1001/jama.1955.02960350004002 Jones, 1978, High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results, Cancer Chemother. Pharmacol., 1, 161, 10.1007/BF00253116 Rothenberg, 2003, Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial, J. Clin. Oncol., 21, 1313, 10.1200/JCO.2003.07.031 Los, 1990, Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment, Cancer Chemother. Pharmacol., 25, 389, 10.1007/BF00686048 Howel, 1982, Intraperitoneal cisplatin with systemic thiosulfate protection, Ann. Intern. Med., 97, 845, 10.7326/0003-4819-97-6-845 de Bree, 2006, Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside, Cancer Treat. Rev., 32, 471, 10.1016/j.ctrv.2006.07.006 Jaaback, 2006, Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer, Cochrane Database Syst. Rev., 10.1002/14651858.CD005340.pub2 Alberts, 1996, Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer, N. Engl. J. Med., 335, 1950, 10.1056/NEJM199612263352603 Gadducci, 2000, Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest, Gynecol. Oncol., 76, 157, 10.1006/gyno.1999.5677 Yen, 2001, Intraperitoneal cisplatin-based chemotherapy versus intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer, Int. J. Gynaecol. Obstet., 72, 55, 10.1016/S0020-7292(00)00340-4 Markman, 2001, J. Clin. Oncol., 19, 1001, 10.1200/JCO.2001.19.4.1001 Armstrong, 2006, Intraperitoneal cisplatin and paclitaxel in ovarian cancer, N. Engl. J. Med., 354, 34, 10.1056/NEJMoa052985 Markman, 2006, Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment, J. Clin. Oncol., 24, 988, 10.1200/JCO.2005.05.2456 Alberts, 2002, Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!, J. Clin. Oncol., 20, 3944, 10.1200/JCO.2002.20.19.3944 Alberts, 2006, Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer, Gynecol. Oncol., 103, 783, 10.1016/j.ygyno.2006.09.012 Jekunen, 1994, Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro, Br. J. Cancer, 69, 299, 10.1038/bjc.1994.55 Rowinsky, 1993, Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine, J. Cancer Res. Clin. Oncol., 119, 727, 10.1007/BF01195344 Fujiwara, 2005, Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer, Gynecol. Oncol., 97, 10, 10.1016/j.ygyno.2004.12.005 Walker, 2006, Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study, Gynecol. Oncol., 100, 27, 10.1016/j.ygyno.2005.11.013